vs

Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and Target Hospitality Corp. (TH). Click either name above to swap in a different company.

Target Hospitality Corp. is the larger business by last-quarter revenue ($73.5M vs $37.2M, roughly 2.0× GYRE THERAPEUTICS, INC.). GYRE THERAPEUTICS, INC. runs the higher net margin — -3.7% vs -20.3%, a 16.7% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs 22.0%). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs 0.7%).

GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.

Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.

GYRE vs TH — Head-to-Head

Bigger by revenue
TH
TH
2.0× larger
TH
$73.5M
$37.2M
GYRE
Growing faster (revenue YoY)
GYRE
GYRE
+11.5% gap
GYRE
33.4%
22.0%
TH
Higher net margin
GYRE
GYRE
16.7% more per $
GYRE
-3.7%
-20.3%
TH
Faster 2-yr revenue CAGR
GYRE
GYRE
Annualised
GYRE
17.0%
0.7%
TH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GYRE
GYRE
TH
TH
Revenue
$37.2M
$73.5M
Net Profit
$-1.4M
$-14.9M
Gross Margin
95.3%
9.6%
Operating Margin
0.3%
-22.9%
Net Margin
-3.7%
-20.3%
Revenue YoY
33.4%
22.0%
Net Profit YoY
-340.1%
-219.1%
EPS (diluted)
$-0.01
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GYRE
GYRE
TH
TH
Q4 25
$37.2M
$73.5M
Q3 25
$30.6M
$91.6M
Q2 25
$26.8M
$54.9M
Q1 25
$22.1M
$54.9M
Q4 24
$27.9M
$60.2M
Q3 24
$25.5M
$65.8M
Q2 24
$25.2M
$67.5M
Q1 24
$27.2M
$72.4M
Net Profit
GYRE
GYRE
TH
TH
Q4 25
$-1.4M
$-14.9M
Q3 25
$5.9M
$-795.0K
Q2 25
$1.6M
$-14.9M
Q1 25
$3.7M
$-6.5M
Q4 24
$569.0K
$12.5M
Q3 24
$2.9M
$20.0M
Q2 24
$4.5M
$18.4M
Q1 24
$9.9M
$20.4M
Gross Margin
GYRE
GYRE
TH
TH
Q4 25
95.3%
9.6%
Q3 25
94.7%
19.6%
Q2 25
95.7%
-0.6%
Q1 25
95.9%
32.7%
Q4 24
95.8%
61.5%
Q3 24
96.2%
68.7%
Q2 24
96.9%
69.4%
Q1 24
96.4%
67.8%
Operating Margin
GYRE
GYRE
TH
TH
Q4 25
0.3%
-22.9%
Q3 25
22.7%
0.1%
Q2 25
8.1%
-30.8%
Q1 25
10.3%
-2.0%
Q4 24
2.4%
34.5%
Q3 24
16.6%
42.5%
Q2 24
12.7%
43.8%
Q1 24
29.7%
42.0%
Net Margin
GYRE
GYRE
TH
TH
Q4 25
-3.7%
-20.3%
Q3 25
19.4%
-0.9%
Q2 25
5.9%
-27.2%
Q1 25
16.9%
-11.8%
Q4 24
2.0%
20.8%
Q3 24
11.2%
30.4%
Q2 24
18.0%
27.2%
Q1 24
36.6%
28.2%
EPS (diluted)
GYRE
GYRE
TH
TH
Q4 25
$-0.01
$-0.14
Q3 25
$0.03
$-0.01
Q2 25
$0.00
$-0.15
Q1 25
$0.00
$-0.07
Q4 24
$0.00
$0.12
Q3 24
$0.01
$0.20
Q2 24
$0.01
$0.18
Q1 24
$0.03
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GYRE
GYRE
TH
TH
Cash + ST InvestmentsLiquidity on hand
$52.4M
$8.3M
Total DebtLower is stronger
$1.7M
Stockholders' EquityBook value
$106.0M
$389.3M
Total Assets
$166.1M
$530.2M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GYRE
GYRE
TH
TH
Q4 25
$52.4M
$8.3M
Q3 25
$60.0M
$30.4M
Q2 25
$54.4M
$19.2M
Q1 25
$29.9M
$34.5M
Q4 24
$26.7M
$190.7M
Q3 24
$25.1M
$177.7M
Q2 24
$25.1M
$154.3M
Q1 24
$37.4M
$124.3M
Total Debt
GYRE
GYRE
TH
TH
Q4 25
$1.7M
Q3 25
$2.0M
Q2 25
$26.3M
Q1 25
$42.9M
Q4 24
$1.5M
Q3 24
$994.0K
Q2 24
$1.1M
Q1 24
$179.9M
Stockholders' Equity
GYRE
GYRE
TH
TH
Q4 25
$106.0M
$389.3M
Q3 25
$101.9M
$402.4M
Q2 25
$92.0M
$401.3M
Q1 25
$68.1M
$415.3M
Q4 24
$63.3M
$421.1M
Q3 24
$63.2M
$417.6M
Q2 24
$60.4M
$397.2M
Q1 24
$56.6M
$375.5M
Total Assets
GYRE
GYRE
TH
TH
Q4 25
$166.1M
$530.2M
Q3 25
$159.4M
$541.2M
Q2 25
$152.6M
$533.7M
Q1 25
$129.8M
$562.5M
Q4 24
$125.4M
$725.8M
Q3 24
$125.2M
$709.8M
Q2 24
$120.9M
$697.0M
Q1 24
$122.0M
$687.2M
Debt / Equity
GYRE
GYRE
TH
TH
Q4 25
0.00×
Q3 25
0.01×
Q2 25
0.07×
Q1 25
0.10×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GYRE
GYRE
TH
TH
Operating Cash FlowLast quarter
$-5.6M
$5.7M
Free Cash FlowOCF − Capex
$-5.8M
FCF MarginFCF / Revenue
-15.5%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-180.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GYRE
GYRE
TH
TH
Q4 25
$-5.6M
$5.7M
Q3 25
$4.7M
$53.4M
Q2 25
$2.1M
$11.1M
Q1 25
$-129.0K
$3.9M
Q4 24
$-2.8M
$30.6M
Q3 24
$1.7M
$31.4M
Q2 24
$-5.5M
$39.1M
Q1 24
$2.9M
$50.6M
Free Cash Flow
GYRE
GYRE
TH
TH
Q4 25
$-5.8M
Q3 25
$4.0M
Q2 25
$1.8M
Q1 25
$-251.0K
$-11.6M
Q4 24
$-2.8M
Q3 24
$1.0M
Q2 24
$-6.9M
Q1 24
$2.7M
FCF Margin
GYRE
GYRE
TH
TH
Q4 25
-15.5%
Q3 25
13.1%
Q2 25
6.8%
Q1 25
-1.1%
-21.1%
Q4 24
-10.1%
Q3 24
4.1%
Q2 24
-27.5%
Q1 24
9.8%
Capex Intensity
GYRE
GYRE
TH
TH
Q4 25
0.4%
Q3 25
2.2%
Q2 25
1.0%
Q1 25
0.6%
28.2%
Q4 24
0.2%
Q3 24
2.7%
Q2 24
5.8%
Q1 24
0.9%
Cash Conversion
GYRE
GYRE
TH
TH
Q4 25
Q3 25
0.79×
Q2 25
1.32×
Q1 25
-0.03×
Q4 24
-4.85×
2.44×
Q3 24
0.60×
1.57×
Q2 24
-1.21×
2.13×
Q1 24
0.29×
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GYRE
GYRE

Segment breakdown not available.

TH
TH

Services$40.9M56%
Hospitality And Facilities Services South$32.6M44%

Related Comparisons